Records 1 - 4
| ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy.
Cancer chemotherapy and pharmacology 2020 Aug .
Nomura Hisanaga, Tsuji Daiki, Demachi Ken, Mochizuki Nobuo, Matsuzawa Haruki, Yano Tomonori, Daiko Hiroyuki, Fujii Satoshi, Kojima Takashi, Itoh Kunihiko, Kawasaki Toshikat
| Association of a genetic variant in ATP-binding cassette sub-family B member 1 gene with poor prognosis in patients with squamous cell carcinoma of the esophagus.
IUBMB life 2019 Mar .
Rastgar-Moghadam Azam, Mehramiz Mehrane, Shahidsales Soodabeh, Entezari Malihe, Hassanian Seyed Mahdi, Talebian Sahar, Nourbakhsh Mahnaz, Ferns Gordon A, Avan Am
| A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Apr 26 (4): 624-44.
Findlay J M, Middleton M R, Tomlinson
| Impact of ABCB1 C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancer.
Pharmacogenomics 2011 Feb 12 (2): 205-14.
Narumiya Kosuke, Metzger Ralf, Bollschweiler Elfriede, Alakus Hakan, Brabender Jan, Drebber Uta, Hölscher Arnulf H, Warnecke-Eberz U